maaf email atau password anda salah

Biomarker Testing for Accurate Drugs

Monday, April 25, 2022

Levana Laksmicitra Sani founded Nalagenetics, a health startup with a focus on pharmacogenomics in Singapore. Through genetic testing, the startup helps improve the efficacy of drugs for several diseases, minimize adverse effects, and reduce the cost of health care.

arsip tempo : 171607337568.

Levana Sani at her work place, April 18. Personal Doc. . tempo : 171607337568.

LEVANA Lasmicitra Sani still remembers how her grandfather passed away several years ago. He died after taking various heart medications prescribed by different doctors. “My grandfather took eight to 12 kinds of drugs,” Levana told Tempo in a video conference on Thursday, April 14.

The founder of Singapore-based Nalagenetics said her grandfather was taken to several doctors because no drug was working. His heart condition remained an


Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

More Articles

More exclusive contents

  • May 13, 2024

  • May 6, 2024

  • April 29, 2024

  • April 22, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe